Could donor cells ease knee pain without surgery?

NCT ID NCT06208241

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This early-phase trial tests the safety of Allocetra-OTS, a cell therapy made from donor immune cells, injected into the knee joint of 18 people with end-stage osteoarthritis who are candidates for surgery. Researchers will monitor side effects and measure pain relief using a standard pain scale. The study is not yet recruiting and focuses on safety first.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Allocetra-OTS (a cell therapy made from donor immune cells)
What this could lead to
If safe and effective, this could point toward a new non-surgical option for severe knee osteoarthritis pain.
What could go wrong
This is a very early, small pilot study with only 18 people, so results may not apply widely. The main goal is safety, not proof of effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kaplan Medical Center

    Rehovot, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.